140 related articles for article (PubMed ID: 2509007)
1. Estimated long-term effect of calcitonin treatment in acute osteoporotic spine fractures.
Resch H; Pietschmann P; Willvonseder R
Calcif Tissue Int; 1989 Oct; 45(4):209-13. PubMed ID: 2509007
[TBL] [Abstract][Full Text] [Related]
2. Effects of one-year hormone replacement therapy on peripheral bone mineral content in patients with osteoporotic spine fractures.
Resch H; Pietschmann P; Krexner E; Woloszczuk W; Willvonseder R
Acta Endocrinol (Copenh); 1990 Jul; 123(1):14-8. PubMed ID: 2389624
[TBL] [Abstract][Full Text] [Related]
3. Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study.
Kaskani E; Lyritis GP; Kosmidis C; Galanos A; Andypas G; Chorianopoulos K; Giagiosis A; Iliadou K; Karagianis A; Katsimichas K; Koskinas A; Matsouka K
Clin Rheumatol; 2005 Jun; 24(3):232-8. PubMed ID: 15647969
[TBL] [Abstract][Full Text] [Related]
4. 17 Beta-estradiol and continuous norethisterone: a unique treatment for established osteoporosis in elderly women.
Christiansen C; Riis BJ
J Clin Endocrinol Metab; 1990 Oct; 71(4):836-41. PubMed ID: 2205624
[TBL] [Abstract][Full Text] [Related]
5. A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis.
Hodsman AB; Fraher LJ; Watson PH; Ostbye T; Stitt LW; Adachi JD; Taves DH; Drost D
J Clin Endocrinol Metab; 1997 Feb; 82(2):620-8. PubMed ID: 9024265
[TBL] [Abstract][Full Text] [Related]
6. Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment.
Civitelli R; Gonnelli S; Zacchei F; Bigazzi S; Vattimo A; Avioli LV; Gennari C
J Clin Invest; 1988 Oct; 82(4):1268-74. PubMed ID: 3262626
[TBL] [Abstract][Full Text] [Related]
7. A randomized study on the effects of estrogen/gestagen or high dose oral calcium on trabecular bone remodeling in postmenopausal osteoporosis.
Steiniche T; Hasling C; Charles P; Eriksen EF; Mosekilde L; Melsen F
Bone; 1989; 10(5):313-20. PubMed ID: 2690898
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of primary osteoporosis with calcium and salmon calcitonin].
Ringe JD
Dtsch Med Wochenschr; 1990 Aug; 115(31-32):1176-82. PubMed ID: 2199180
[TBL] [Abstract][Full Text] [Related]
9. Treatment of postmenopausal osteoporosis with salmon calcitonin nasal spray: evaluation by bone mineral content and biochemical patterns.
Tolino A; Romano L; Ronsini S; Riccio S; Montemagno U
Int J Clin Pharmacol Ther Toxicol; 1993 Jul; 31(7):358-60. PubMed ID: 8370634
[TBL] [Abstract][Full Text] [Related]
10. Three-year calcitonin combination therapy for postmenopausal osteoporosis with crush fractures of the spine.
Szücs J; Horváth C; Kollin E; Szathmári M; Holló I
Calcif Tissue Int; 1992 Jan; 50(1):7-10. PubMed ID: 1739873
[TBL] [Abstract][Full Text] [Related]
11. [Clinical efficacy of treatment with salmon calcitonin, administered intranasally for 1 year, in stabilized postmenopausal osteoporosis].
Agnusdei D; Gonnelli S; Camporeale A; Batignani T; Nardi P; Ianes A; Gennari C
Minerva Endocrinol; 1989; 14(3):169-76. PubMed ID: 2695815
[TBL] [Abstract][Full Text] [Related]
12. Total and regional bone mineral content and fracture rate in postmenopausal osteoporosis treated with salmon calcitonin: a prospective study.
Rico H; Revilla M; Hernández ER; Villa LF; Alvarez de Buergo M
Calcif Tissue Int; 1995 Mar; 56(3):181-5. PubMed ID: 7750020
[TBL] [Abstract][Full Text] [Related]
13. [Salmon calcitonin in osteoporosis. The effect of intranasal application on bone mineral content and fracture frequency in postmenopausal women with manifest osteoporotic changes].
Overgaard K; Ravn P; Hansen MA; Christiansen C
Ugeskr Laeger; 1993 Aug; 155(31):2387-91. PubMed ID: 8346588
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of postmenopausal spinal and long bone fractures. A unifying approach to postmenopausal osteoporosis.
Jensen GF; Christiansen C; Boesen J; Hegedüs V; Transbøl I
Clin Orthop Relat Res; 1982 Jun; (166):75-81. PubMed ID: 7083689
[TBL] [Abstract][Full Text] [Related]
15. Treatment of osteoporosis with calcitonin, with and without growth hormone.
Aloia JF; Vaswani A; Kapoor A; Yeh JK; Cohn SH
Metabolism; 1985 Feb; 34(2):124-9. PubMed ID: 3969014
[TBL] [Abstract][Full Text] [Related]
16. Discontinuous calcitonin treatment of established osteoporosis--effects of withdrawal of treatment.
Overgaard K; Hansen MA; Nielsen VA; Riis BJ; Christiansen C
Am J Med; 1990 Jul; 89(1):1-6. PubMed ID: 2152594
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of regional bone measurements in patients with osteoporotic fractures of the spine and distal forearm.
Nilas L; Pødenphant J; Riis BJ; Gotfredsen A; Christiansen C
J Nucl Med; 1987 Jun; 28(6):960-5. PubMed ID: 3585503
[TBL] [Abstract][Full Text] [Related]
18. A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group.
Chesnut CH; Silverman S; Andriano K; Genant H; Gimona A; Harris S; Kiel D; LeBoff M; Maricic M; Miller P; Moniz C; Peacock M; Richardson P; Watts N; Baylink D
Am J Med; 2000 Sep; 109(4):267-76. PubMed ID: 10996576
[TBL] [Abstract][Full Text] [Related]
19. Does 1,25(OH)2D3 accelerate spinal bone loss? A controlled therapeutic trial in 70-year-old women.
Jensen GF; Meinecke B; Boesen J; Transbøl I
Clin Orthop Relat Res; 1985; (192):215-21. PubMed ID: 3881203
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of the effectiveness of 17-beta-estradiol and calcitonin in women with postmenopausal bone loss].
Stĕpán J; Formánková J; Masatová A; Michalský M; Rosenová Z
Cas Lek Cesk; 1997 Apr; 136(8):242-8. PubMed ID: 9264868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
